56/100BCVS HEALTH financials
Yes. CVS HEALTH earned 11.05B USD of net income over the last twelve months, 2.6% of its revenue. It made a profit in 39 of its 41 fiscal years since 1985. Its last loss was in fiscal year 2018.
- Revenue (TTM)
- 420.61B USD
- Net income (TTM)
- 11.05B USD
- Free cash flow (TTM)
- 15.57B USD
- Cash and short-term investments
- 14.89B USD
- Total debt
- 75.30B USD
- Shareholders' equity
- 80.50B USD
Cash, debt and equity as of 30 Sept 2026.
CVS HEALTH earnings
Revenue
EPS
| Period | Report date | EPS estimate | Reported EPS | Surprise | EPS growth | Revenue estimate | Reported revenue | Surprise | Revenue growth |
|---|---|---|---|---|---|---|---|---|---|
| Q3 FY2027 | 1.88 | — | — | -9.87% | 107.86B | — | — | -0.50% | |
| Q2 FY2027 | 2.56 | — | — | -0.94% | 107.80B | — | — | +1.61% | |
| Q1 FY2027 | 2.68 | — | — | +4.40% | 102.74B | — | — | +2.30% | |
| Q4 FY2026 | 1.22 | — | — | +11.93% | 107.17B | — | — | +1.40% | |
| Q3 FY2026 | 1.65 | 2.09 | +26.67% | +30.62% | 104.72B | 108.40B | +3.51% | +5.37% | |
| Q2 FY2026 | 1.85 | 2.58 | +39.46% | +42.54% | 100.03B | 106.10B | +6.07% | +7.26% | |
| Q1 FY2026 | 2.18 | 2.57 | +17.89% | +14.22% | 94.99B | 100.43B | +5.72% | +6.17% | |
| Q4 FY2025 | 1.00 | 1.09 | +9.00% | -8.40% | 103.70B | 105.69B | +1.92% | +8.17% | |
| Q3 FY2025 | 1.37 | 1.60 | +16.79% | +46.79% | 98.81B | 102.87B | +4.11% | +7.80% | |
| Q2 FY2025 | 1.46 | 1.81 | +23.97% | -1.09% | 94.53B | 98.92B | +4.64% | +8.42% |
| Period | EPS estimate | Reported EPS | Surprise | EPS growth | Revenue estimate | Reported revenue | Surprise | Revenue growth |
|---|---|---|---|---|---|---|---|---|
| FY2028 | 9.70 | — | — | +13.83% | 449.26B | — | — | +4.52% |
| FY2027 | 8.53 | — | — | +5.91% | 429.85B | — | — | +2.91% |
| FY2026 | 8.05 | — | — | +19.25% | 417.68B | — | — | +3.88% |
| FY2025 | 6.67 | 6.75 | +1.24% | +24.54% | 400.14B | 402.07B | +0.48% | +7.85% |
| FY2024 | 5.14 | 5.42 | +5.40% | -37.99% | 371.87B | 372.81B | +0.25% | +4.20% |
| FY2023 | 8.61 | 8.74 | +1.56% | +0.46% | 354.36B | 357.78B | +0.96% | +10.95% |
| FY2022 | 8.63 | 8.70 | +0.81% | +3.45% | 315.12B | 322.47B | +2.33% | +10.39% |
CVS HEALTH growth and profitability
Full income statement- Revenue (TTM)
- 420.61B USD
- Net income (TTM)
- 11.05B USD
- Gross margin
- 14.23%
- Operating margin
- 3.58%
- Net margin
- 2.63%
Revenue / Net income
How CVS HEALTH makes its money
FY2025, in USD. Each band is as wide as its money; the percentage is its share of revenue.
FY2025, in USD. Each band is as wide as its money; the percentage is its share of revenue.
CVS HEALTH revenue breakdown
By product
| Segment | Revenue | Share of revenue | Change on the year |
|---|---|---|---|
| Pharmacy Revenue | 229.03B | 58.9% | +8.9% |
| Premiums | 134.75B | 34.6% | +9.6% |
| Front Store Revenue | 21.46B | 5.5% | -0.3% |
| Product and Service, Other | 3.93B | 1.0% | -75.4% |
Operating and free cash flow
Full cash flow statementCVS HEALTH financial health
Full balance sheet- Cash and short-term investments
- 14.89B USD
- Total debt
- 75.30B USD
- Net cash
- -60.41B USD
- Free cash flow (TTM)
- 15.57B USD
- Current ratio
- 0.85
- Debt to equity
- 0.94
- Piotroski score
- 8 / 9
- Altman Z-score
- 2.47
Cash, debt and free cash flow
Assets, liabilities and equity
CVS HEALTH valuation
- Price to earnings ratio (TTM)
- 9.68
- Forward P/E (FY2026)
- 10.42
- Price to sales (TTM)
- 0.26
- Price to book
- 1.33
- EV / EBITDA (TTM)
- 8.51
Capital structure
Valuation over time
CVS HEALTH against its own history
Each figure in the latest fiscal year against the same figure from FY2021 to FY2025: the range, its median (the line) and the latest (the dot, green on the good side of the median). The P/E is today's against its daily readings of five years.
Its peers: Elevance Health, Cigna, Humana, Centene, UnitedHealth Group, and Molina Healthcare, the US Medical - Healthcare Plans companies closest to it in size, each in its own latest fiscal year: their median (the line) and its rank among them, first being the best.
- P/E (today)Below its median9.79.4202.1
- Gross marginLowest in 5 years13.8%13.8%17.8%Against its peers: 4 of 7Peers' median 13.4%
- Operating marginAt its median2.6%2.3%4.6%Against its peers: 4 of 7Peers' median 2.5%
- Net marginLowest in 5 years0.4%0.4%2.7%Against its peers: 6 of 7Peers' median 1.6%
- Return on equityLowest in 5 years2.4%2.4%10.9%Against its peers: 6 of 7Peers' median 12.2%
- Free cash flow marginBelow its median1.9%1.7%5.4%Against its peers: 4 of 7Peers' median 1.9%
- Revenue growthBelow its median7.8%4.2%10.9%Against its peers: 7 of 7Peers' median 11.8%
- EPS growthLowest in 5 years-62.0%-62.0%98.5%Against its peers: 6 of 7Peers' median -8.4%
- Debt to EBITDAHighest in 5 years9.49×4.34×9.49×Against its peers: 6 of 6Peers' median 3.44×
- Current ratioBelow its median0.840.810.95Against its peers: 5 of 7Peers' median 1.04
Peers: US companies of the same industry (of its sector when the industry has too few) from a tenth to ten times its market value, the six closest in size. Updated weekly.
CVS HEALTH dividends
- Annual dividend
- 2.66 USD
- Dividend yield (indicated)
- 3.17%
- Payout ratio
- 30.72%
- Frequency
- Quarterly
- Last payment
- 0.67 USD
- Last ex-dividend date
- 22 Oct 2026
- Last payment date
- 2 Nov 2026
Dividends per share
CVS HEALTH ownership
- Institutions
- 90.26%
- Institutional holders
- 2,182 (+208)
- Free float
- 99.84%
Who owns the shares
Shares free to trade
Closely held shares belong to insiders, founders and owners of more than 5%, and seldom change hands. The free float is the rest: the shares anyone can buy and sell.
Insider trading
| Quarter | Purchases | Sales | Shares acquired | Shares disposed of |
|---|---|---|---|---|
| Q2 2026 | 0 | 9 | 19.06K | 3.89M |
| Q1 2026 | 0 | 0 | 983.54K | 10.08K |
| Q4 2025 | 0 | 0 | 20.20K | 26.01K |
| Q3 2025 | 0 | 1 | 0.00 | 27.33K |
Shares outstanding
Common questions about CVS HEALTH's financials
Source: Financial Modeling Prep